×

Stocks Abbott Laboratories

  • graphic_word_ofthe_street.jpg

    The S&P tumbled on Monday largely due to concerns about the major automakers.

  • At the start of the month, General Electric was falling fast and the company that once boasted a half trillion dollar market cap, was at risk of falling out of the Top 20 biggest companies in the S&P 500.  In less than a month, that has changed significantly.

  • graphic_fast_fire.jpg

    Sometimes a stock is hot and other times it just burns you. Following are trades that didn’t end so well.

  • Genetech

    Art Levinson and Miles White are "Kings of the Jungle." At least Barron's thinks they are. The weekly investment periodical picked the pair as the only two from biopharma to make its annual list of the "30 Most Respected CEOs."

  • graphic_word_ofthe_street.jpg

    The Dow fell on Thursday largely due to concerns that the Federal Reserve's latest efforts to battle the recession are too costly and untested...

  • Health care stocks have lost their defensive appeal and feeling rather ill for the past few weeks. Shares of healthcare companies, United Health Care and Humana have dropped significantly since the Obama administration outlined a healthcare reform agenda aimed at cutting $175 billion in payments over 10 years to private insurers through the Medicare Advantage Program.

  • graphic_final_trade.jpg

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Cramer makes the call on viewers' favorite stocks.

  • Looking for a formula for successful stock investing?  RBC Bank's Joseph Keating sums it up in three words:  exceptionally high quality.  Companies in that category, he says, are likeliest to hold onto their dividends. (Part Two)

  • peanutbutter_letter1a.jpg

    Last week, I got two notices that were labeled on the outside as being from Costco and regarding a "Food Safety Recall Notice." They're related to the ongoing peanut (Salmonella) problem.

  • Companies that can, do. The rest? They cost the Dow 122 points on Wednesday. Cramer pays homage to peak performance.

  • Gerald Jordan of the Jordan Opportunity Fund sees a big rally coming, probably in the second quarter, and he believes investors should get back into stocks to get ready for it.  "I think the next two to three thousand points in the Dow are going to be higher, not lower, and that's what we're invested for," he told CNBC.

  • Who's next in the potential wave of consolidation set off by Pfizer and Wyeth? Cramer has an idea.

  • At the end of a short but turbulent week that included the official start of the Barack Obama administration, Alan Valdes of Hilliard Lyons offered some stock suggestions inspired by the new president and his policies. "We like his health care plan," Valdes told CNBC. 

  • credit_crisis_03.jpg

    The ailing banking system is at the top of the Obama Administration's agenda Wednesday, after worries about the sector Tuesday handed the stock market its worse Inauguration Day losses ever.

  • johnson_johnson2_logo.jpg

    Dow component and giant healthcare company--you really can't lump it in with big pharma because it sells drugs, medical devices and consumer products--Johnson & Johnson reported earnings this morning.

  • obama_barack_6.jpg

    Stocks will struggle with a heavy dose of bad earnings news that could dash investor hopes for an Obama rally in the week ahead.

  • webxtra_thumb.jpg

    In this Web Extra the traders reveal how they're gaming Bernake's Tuesday speech, a Mosaic investor meeting, the JP Morgan Healthcare conference and more.

  • graphic_word_ofthe_street.jpg

    The Dow fell for the fourth day in a row as concerns about massive losses at Citigroup knocked its shares 17 percent lower, dragging down bank stocks...

  • Stocks continued their slide Monday as the economy and what is expected to be a horrendous earnings season formed a one-two punch to knock out hopes for a January rally.